Risk estimation by PRS using the identified genome-wide significant SNPs for NAFLD clearly showed that the effect of the risk alleles, namely PNPLA3, GATAD2A, and GCKR was cumulative and increased the risk for NAFLD. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.